LPCN

NASDAQStock

Lipocine Inc.

$7.77-0.28 (-3.48%)

52-Week Range

$2.53

$11.26

Key Stats

Market Cap

—

P/E Ratio

—

Dividend Yield

—

Beta

1.01

Volume

116.3K

Avg Volume

150.4K

Performance

-7.15%

+155.56%

+171.04%

YTD

+0.63%

+140.30%

+53.30%

-71.30%

Price Chart

ETF Exposure

LPCN is held by 8 ETFs

ETF	Fund Name	Weight	Shares	Market Value	Fund AUM	Expense Ratio
DFSU	Dimensional - US Sustainability Core 1 ETF	0.00%	2,500	$20K	$1.87B	0.15%
VXF	Vanguard Extended Market ETF	0.00%	57,895	$521K	$84.10B	0.05%
VCNS.TO	Vanguard Conservative ETF Portfolio	0.00%	7	$85	$820.6M	0.25%
VEQT.TO	Vanguard All-Equity ETF Portfolio	0.00%	250	$3K	$12.17B	0.24%
VRIF.TO	Vanguard Retirement Income ETF Portfolio	0.00%	1	$14	$337.7M	0.32%
VTI	Vanguard Total Stock Market ETF	0.00%	142,773	$1.3M	$2.10T	0.03%
VUN.TO	Vanguard U.S. Total Market Index ETF	0.00%	750	$9K	$15.33B	0.17%
VUS.TO	Vanguard U.S. Total Market Index ETF (CAD-hedged)	0.00%	64	$789	$1.29B	0.17%

About LPCN ETF Exposure

Lipocine Inc. (LPCN) is held by 8 exchange-traded funds, making it one of the stocks with significant ETF exposure. The stock currently trades at $7.77. Investors can gain exposure to LPCN through a variety of ETFs with different expense ratios, investment strategies, and portfolio weightings. The table above shows all ETFs that currently hold LPCN, sorted by portfolio weight.